Literature DB >> 24492342

NFκB induces overexpression of bovine FcRn: a novel mechanism that further contributes to the enhanced immune response in genetically modified animals carrying extra copies of FcRn.

Judit Cervenak1, Márton Doleschall2, Balázs Bender1, Balázs Mayer3, Zita Schneider4, Zoltán Doleschall5, Yaofeng Zhao6, Zsuzsanna Bősze7, Lennart Hammarström8, Wolfgang Oster1, Imre Kacskovics9.   

Abstract

Among the many functions of the neonatal Fc receptor (FcRn) for IgG, it binds to IgG-opsonized antigen complexes and propagates their traffic into lysosomes where antigen processing occurs. We previously reported that transgenic (Tg) mice and rabbits that carry multiple copies and overexpress FcRn have augmented humoral immune responses. Nuclear factor-kappa B (NFκB) is a critical molecule in the signaling cascade in the immune response. NFκB induces human FcRn expression and our previous in silico analysis suggested NFκB binding sites in the promoter region of the bovine (b) FcRn α-chain gene (FCGRT). Here, we report the identification of three NFκB transcription binding sites in the promoter region of this gene using luciferase reporter gene technology, electromobility shift assay and supershift analysis. Stimulation of primary bovine endothelial cells with the Toll-like receptor-4 ligand lipopolysaccharide (LPS), which mediates its effect via NFκB, resulted in rapid upregulation of the bFcRn expression and a control gene, bovine E-selectin. This rapid bFcRn gene induction was also observed in the spleen of bFcRn Tg mice treated with intraperitoneally injected LPS, analyzed by northern blot analysis. Finally, NFκB-mediated bFcRn upregulation was confirmed at the protein level in macrophages isolated from the bFcRn Tg mice using flow cytometry with a newly developed FcRn specific monoclonal antibody that does not cross-react with the mouse FcRn. We conclude that NFκB regulates bFcRn expression and thus optimizes its functions, e.g., in the professional antigen presenting cells, and contributes to the much augmented humoral immune response in the bFcRn Tg mice.

Entities:  

Keywords:  FcRn; IgG; NFκB; antigen presentation; humoral; immune response; transgenic mouse

Mesh:

Substances:

Year:  2013        PMID: 24492342      PMCID: PMC3896600          DOI: 10.4161/mabs.26507

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  56 in total

1.  A THEORETICAL MODEL OF GAMMA-GLOBULIN CATABOLISM.

Authors:  F W BRAMBELL; W A HEMMINGS; I G MORRIS
Journal:  Nature       Date:  1964-09-26       Impact factor: 49.962

2.  FcRn: an IgG receptor on phagocytes with a novel role in phagocytosis.

Authors:  Gestur Vidarsson; Annette M Stemerding; Nigel M Stapleton; Suzanne E Spliethoff; Hans Janssen; Frank E Rebers; Masja de Haas; Jan G van de Winkel
Journal:  Blood       Date:  2006-07-18       Impact factor: 22.113

Review 3.  Introduction to NF-kappaB: players, pathways, perspectives.

Authors:  T D Gilmore
Journal:  Oncogene       Date:  2006-10-30       Impact factor: 9.867

4.  Characterization of the nuclear factor-kappa B responsiveness of the human dio2 gene.

Authors:  Anikó Zeöld; Márton Doleschall; Michael C Haffner; Luciane P Capelo; Judit Menyhért; Zsolt Liposits; Wagner S da Silva; Antonio C Bianco; Imre Kacskovics; Csaba Fekete; Balázs Gereben
Journal:  Endocrinology       Date:  2006-05-25       Impact factor: 4.736

5.  Cloning, expression and characterization of the bovine p65 subunit of NFkappaB.

Authors:  Márton Doleschall; Balázs Mayer; Judit Cervenak; László Cervenak; Imre Kacskovics
Journal:  Dev Comp Immunol       Date:  2007-01-24       Impact factor: 3.636

6.  Functional analysis of the mouse Fcgrt 5' proximal promoter.

Authors:  Bhavna Tiwari; Richard P Junghans
Journal:  Biochim Biophys Acta       Date:  2004-11-24

7.  Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune disease.

Authors:  Stefka B Petkova; Shreeram Akilesh; Thomas J Sproule; Gregory J Christianson; Hana Al Khabbaz; Aaron C Brown; Leonard G Presta; Y Gloria Meng; Derry C Roopenian
Journal:  Int Immunol       Date:  2006-10-31       Impact factor: 4.823

8.  FcRn mediates elongated serum half-life of human IgG in cattle.

Authors:  Imre Kacskovics; Zsuzsanna Kis; Balázs Mayer; Anthony P West; Noreen E Tiangco; Mulualem Tilahun; László Cervenak; Pamela J Bjorkman; Richard A Goldsby; Ottó Szenci; Lennart Hammarström
Journal:  Int Immunol       Date:  2006-02-15       Impact factor: 4.823

9.  Position independent and copy-number-related expression of the bovine neonatal Fc receptor alpha-chain in transgenic mice carrying a 102 kb BAC genomic fragment.

Authors:  Balázs Bender; Lilla Bodrogi; Balázs Mayer; Zita Schneider; Yaofeng Zhao; Lennart Hammarström; André Eggen; Imre Kacskovics; Zsuzsanna Bosze
Journal:  Transgenic Res       Date:  2007-06-27       Impact factor: 2.788

10.  NF-kappaB signaling regulates functional expression of the MHC class I-related neonatal Fc receptor for IgG via intronic binding sequences.

Authors:  Xindong Liu; Lilin Ye; Gregory J Christianson; Jun-Qi Yang; Derry C Roopenian; Xiaoping Zhu
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

View more
  10 in total

Review 1.  Bile acid transporter-mediated oral drug delivery.

Authors:  Feiyang Deng; You Han Bae
Journal:  J Control Release       Date:  2020-07-22       Impact factor: 9.776

2.  A unique haplotype of RCCX copy number variation: from the clinics of congenital adrenal hyperplasia to evolutionary genetics.

Authors:  Márton Doleschall; Andrea Luczay; Klára Koncz; Kinga Hadzsiev; Éva Erhardt; Ágnes Szilágyi; Zoltán Doleschall; Krisztina Németh; Dóra Török; Zoltán Prohászka; Balázs Gereben; György Fekete; Edit Gláz; Péter Igaz; Márta Korbonits; Miklós Tóth; Károly Rácz; Attila Patócs
Journal:  Eur J Hum Genet       Date:  2017-04-12       Impact factor: 4.246

Review 3.  Colostrogenesis: Role and Mechanism of the Bovine Fc Receptor of the Neonate (FcRn).

Authors:  Craig R Baumrucker; Ann L Macrina; Rupert M Bruckmaier
Journal:  J Mammary Gland Biol Neoplasia       Date:  2022-01-26       Impact factor: 2.673

4.  On the perplexingly low rate of transport of IgG2 across the human placenta.

Authors:  Helga K Einarsdottir; Nigel M Stapleton; Sicco Scherjon; Jan Terje Andersen; Theo Rispens; C Ellen van der Schoot; Gestur Vidarsson
Journal:  PLoS One       Date:  2014-09-24       Impact factor: 3.240

5.  TGEV infection up-regulates FcRn expression via activation of NF-κB signaling.

Authors:  Jinyue Guo; Fei Li; Shaoju Qian; Dingren Bi; Qigai He; Hui Jin; Rui Luo; Shaowen Li; Xianrong Meng; Zili Li
Journal:  Sci Rep       Date:  2016-08-24       Impact factor: 4.379

6.  Activation of the JNK/MAPK Signaling Pathway by TGF-β1 Enhances Neonatal Fc Receptor Expression and IgG Transcytosis.

Authors:  Shaoju Qian; Chenxi Li; Xi Liu; Xiangchao Jia; Yuncai Xiao; Zili Li
Journal:  Microorganisms       Date:  2021-04-20

7.  Overexpression of Bovine FcRn in Mice Enhances T-Dependent Immune Responses by Amplifying T Helper Cell Frequency and Germinal Center Enlargement in the Spleen.

Authors:  Zita Schneider; Péter Károly Jani; Bence Szikora; Attila Végh; Dorottya Kövesdi; Attila Iliás; Judit Cervenak; Péter Balogh; István Kurucz; Imre Kacskovics
Journal:  Front Immunol       Date:  2015-07-20       Impact factor: 7.561

8.  Analysis of Response Elements Involved in the Regulation of the Human Neonatal Fc Receptor Gene (FCGRT).

Authors:  Joanna E Mikulska
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

Review 9.  Immunoglobulin Transporting Receptors Are Potential Targets for the Immunity Enhancement and Generation of Mammary Gland Bioreactor.

Authors:  Xuemei Jiang; Jianjun Hu; Diraviyam Thirumalai; Xiaoying Zhang
Journal:  Front Immunol       Date:  2016-06-10       Impact factor: 7.561

10.  Functional humanization of immunoglobulin heavy constant gamma 1 Fc domain human FCGRT transgenic mice.

Authors:  Benjamin E Low; Gregory J Christianson; Emily Lowell; Wenning Qin; Michael V Wiles
Journal:  MAbs       Date:  2020 Jan-Dec       Impact factor: 5.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.